Cargando…
Development of (68)Ga-labelled ultrasound microbubbles for whole-body PET imaging
Microbubble (MB) contrast agents have revolutionalised the way ultrasound (US) imaging can be used clinically and pre-clinically. Contrast-enhanced US offers improvements in soft-tissue contrast, as well as the ability to visualise disease processes at the molecular level. However, its inability to...
Autores principales: | Hernández-Gil, Javier, Braga, Marta, Harriss, Bethany I., Carroll, Laurence S., Leow, Chee Hau, Tang, Meng-Xing, Aboagye, Eric O., Long, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552490/ https://www.ncbi.nlm.nih.gov/pubmed/31293745 http://dx.doi.org/10.1039/c9sc00684b |
Ejemplares similares
-
Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018) -
PET imaging of PARP expression using (68)Ga-labelled inhibitors
por: Wang, Xiangwei, et al.
Publicado: (2023) -
Investigating CXCR4 expression of tumor cells and the vascular compartment: A multimodal approach
por: Braga, Marta, et al.
Publicado: (2021) -
[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020) -
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients
por: Berzaczy, Dominik, et al.
Publicado: (2017)